INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);UNIVERSITE PARIS-SUD
发明人:
Olivier CHRISTOPHE,Cecile DENIS,Peter LENTING
申请号：
US16846939
公开号：
US20200248162A1
申请日:
2020.04.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to mutated factor (FX) polypeptides and uses thereof for the treatment of haemophilia. In particular, the present invention relates to a mutated factor X (FX) polypeptide which comprises a heavy chain wherein at least one amino acid residue at position 401 or 408 is mutated.
